Plancorp, LLC Biogen Inc. Transaction History

Plancorp, LLC

$2.3 Billion
Q2 2024

A detailed history of Plancorp, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Plancorp, LLC holds 1,603 shares of BIIB stock, worth $278,585. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,603

Previous 1,606 0.19%

Holding current value

$278,585

Previous $346,000 7.23%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$190.52 - $236.72 $571 - $710	-3 Reduced 0.19%	1,603 $371,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $13,357 - $16,865	-63 Reduced 3.77%	1,606 $346,000
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $27,378 - $32,956	123 Added 7.96%	1,669 $431,000
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $2,533 - $2,858	10 Added 0.65%	1,546 $397,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $513 - $584	-2 Reduced 0.13%	1,536 $427,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $4,796 - $5,827	19 Added 1.25%	1,538 $425,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $5,061 - $6,979	26 Added 1.74%	1,519 $406,000
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $562 - $669	-3 Reduced 0.2%	1,493 $304,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $16,470 - $20,751	-85 Reduced 5.38%	1,496 $315,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $5,374 - $6,906	-24 Reduced 1.5%	1,581 $379,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $27,733 - $36,166	-98 Reduced 5.75%	1,605 $454,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $6,993 - $11,197	27 Added 1.61%	1,703 $590,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $242 - $284	-1 Reduced 0.06%	1,676 $469,000
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $10,395 - $15,647	-44 Reduced 2.56%	1,677 $411,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $455,669 - $526,126	1,721 New	1,721 $488,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $656,115 - $723,226	-2,992 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $19,720 - $30,845	91 Added 3.14%	2,992 $707,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $3,063 - $3,880	11 Added 0.38%	2,901 $873,000
Q4 2017 Jan 19, 2018	SELL	$307.64 - $344.58 $1,538 - $1,722	-5 Reduced 0.17%	2,890 $921,000
Q3 2017 Oct 11, 2017	BUY	$281.15 - $329.69 $813,929 - $954,452	2,895	2,895 $907,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.

Account